He has built a long-standing career in research and development with core expertise in molecular biology, assay development, and DNA-encoded library screening. His industry experience spans both biotech and regulatory environments and includes contributions to early-stage drug discovery, technology development, and the implementation of next-generation sequencing–based screening platforms. His career includes roles at companies such as CCBR Clinical Research and Rheoscience, as well as an extended period at Vipergen supporting the maturation of DNA-encoded library technologies.